Eric L. Staals

Pexidartinib: First Approval

Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma

Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing

Common Musculoskeletal Tumors of Childhood and Adolescence

Macrophages in immunoregulation and therapeutics

Update on hypoxia-inducible factors and hydroxylases in oxygen regulatory pathways: from physiology to therapeutics

What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer

Osteosarcoma treatment – Where do we stand? A state of the art review

Percutaneous needle biopsy in diagnosis and identification of causative organisms in cases of suspected vertebral osteomyelitis

Sarcomas Across the Age Spectrum

Childhood and adolescent cancer statistics, 2014

Molecular oncogenesis of chondrosarcoma: impact for targeted treatment

2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa

The Clinical Approach Towards Chondrosarcoma

Natural product and natural product derived drugs in clinical trials

Dedifferentiated central chondrosarcoma

Percutaneous CT-guided biopsy of the spine: results of 430 biopsies

Dedifferentiated Chondrosarcomas Arising in Preexisting Osteochondromas

The Treatment of Nonmetastatic High Grade Osteosarcoma of the Extremity: Review of the Italian Rizzoli Experience. Impact on the Future

Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes

Periosteal osteosarcoma

Synovial sarcoma

Sex- and Age-Related Chemotherapy Toxicity in Patients with Non-Metastatic Osteosarcoma

Dedifferentiated Chondrosarcomas Arising in Preexisting Osteochondromas

First prospective observational study in diffuse-type tenosynovial giant cell tumors.